• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机会性侵袭性真菌病的流行病学

Epidemiology of opportunistic invasive mycoses.

作者信息

Kullberg B J, Oude Lashof A M L

机构信息

Nijmegen Center for Infectious Diseases and Department of Medicine (541), Nijmegen University Medical Center St Radboud, Geert Grooteplein 8, 6525 GA Nijmegen, The Netherlands.

出版信息

Eur J Med Res. 2002 May 31;7(5):183-91.

PMID:12069910
Abstract

Invasive aspergillosis and disseminated candidiasis are the two major manifestations of opportunistic invasive mycoses. Their incidence has risen considerably during the past decades, due to more intensive anticancer chemotherapy, organ transplantations, intensive care, and aggressive surgical interventions. Especially bone marrow transplant recipients are at risk for developing invasive aspergillosis. Whether the infection is acquired through contaminated water or through airborne spores is a matter of much debate. Candidemia and disseminated candidiasis commonly originate from the gastrointestinal tract. Abdominal surgery and mucosal damage due to anticancer chemotherapy are the majors factor through which gut colonization may lead to invasive disease. A shift in the epidemiology of disseminated candidiasis has been noted, with an increasing incidence of Candida glabrata, C. tropicalis and C. krusei strains.

摘要

侵袭性曲霉病和播散性念珠菌病是机会性侵袭性真菌病的两种主要表现形式。在过去几十年中,由于更强化的抗癌化疗、器官移植、重症监护以及积极的外科手术干预,它们的发病率显著上升。尤其是骨髓移植受者有发生侵袭性曲霉病的风险。感染是通过受污染的水还是空气传播的孢子获得,这是一个备受争议的问题。念珠菌血症和播散性念珠菌病通常起源于胃肠道。腹部手术和抗癌化疗导致的黏膜损伤是肠道定植可能导致侵袭性疾病的主要因素。已注意到播散性念珠菌病的流行病学发生了变化,光滑念珠菌、热带念珠菌和克柔念珠菌菌株的发病率不断增加。

相似文献

1
Epidemiology of opportunistic invasive mycoses.机会性侵袭性真菌病的流行病学
Eur J Med Res. 2002 May 31;7(5):183-91.
2
Changing patterns and trends in systemic fungal infections.系统性真菌感染的变化模式与趋势
J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i5-i11. doi: 10.1093/jac/dki218.
3
[Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants].[实体器官移植受者中的念珠菌病、曲霉病及其他侵袭性真菌病]
Rev Iberoam Micol. 2011 Jul-Sep;28(3):110-9. doi: 10.1016/j.riam.2011.06.002.
4
Management of mycoses in surgical patients -- review of the literature.外科患者真菌病的管理——文献综述
Eur J Med Res. 2002 May 31;7(5):200-26.
5
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).重症监护中侵袭性念珠菌感染的流行病学、管理及死亡风险因素:法国一项多中心、前瞻性、观察性研究(2005 - 2006年)
Crit Care Med. 2009 May;37(5):1612-8. doi: 10.1097/CCM.0b013e31819efac0.
6
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.使用甲硝唑、环丙沙星和氟康唑或环丙沙星与氟康唑进行肠道去污的异基因骨髓移植后的真菌定植和侵袭性真菌感染。
Bone Marrow Transplant. 2000 Nov;26(9):993-7. doi: 10.1038/sj.bmt.1702655.
7
Epidemiology of opportunistic fungal infections in Latin America.拉丁美洲机会性真菌感染的流行病学。
Clin Infect Dis. 2010 Sep 1;51(5):561-70. doi: 10.1086/655683.
8
Epidemiology of candidemia in intensive care units.重症监护病房念珠菌血症的流行病学
Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S87-91. doi: 10.1016/S0924-8579(08)70006-2.
9
Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.肝移植术后侵袭性念珠菌病和非念珠菌真菌感染的谱系及危险因素
Chin Med J (Engl). 2008 Apr 5;121(7):625-30.
10
Invasive fungal infections in Kuwait: A retrospective study.科威特的侵袭性真菌感染:一项回顾性研究。
Indian J Chest Dis Allied Sci. 2000 Oct-Dec;42(4):279-87.

引用本文的文献

1
What do We Know about Cryptic Aspergillosis?我们对隐匿性曲霉病了解多少?
Microorganisms. 2024 Apr 28;12(5):886. doi: 10.3390/microorganisms12050886.
2
Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of and .孔形成肽 C14R 对 和 的临床分离株表现出强大的抗真菌活性。
Front Cell Infect Microbiol. 2024 Mar 27;14:1389020. doi: 10.3389/fcimb.2024.1389020. eCollection 2024.
3
Variation in transcription regulator expression underlies differences in white-opaque switching between the SC5314 reference strain and the majority of Candida albicans clinical isolates.
转录调控因子表达的差异是 SC5314 参考株与大多数白念珠菌临床分离株之间白-淡色转换差异的基础。
Genetics. 2023 Nov 1;225(3). doi: 10.1093/genetics/iyad162.
4
Farnesol and phosphorylation of the transcriptional regulator Efg1 affect Candida albicans white-opaque switching rates.法呢醇和转录调控因子 Efg1 的磷酸化影响白念珠菌白-暗相转换率。
PLoS One. 2023 Jan 20;18(1):e0280233. doi: 10.1371/journal.pone.0280233. eCollection 2023.
5
Appropriate empirical antifungal therapy is associated with a reduced mortality rate in intensive care unit patients with invasive fungal infection: A real-world retrospective study based on the MIMIC-IV database.适当的经验性抗真菌治疗与重症监护病房侵袭性真菌感染患者死亡率降低相关:一项基于MIMIC-IV数据库的真实世界回顾性研究。
Front Med (Lausanne). 2022 Sep 20;9:952611. doi: 10.3389/fmed.2022.952611. eCollection 2022.
6
Network Analysis Guided Designing of Multi-Targeted Anti-Fungal Agents: Synthesis and Biological Evaluation.网络分析指导下的多靶点抗真菌药物设计:合成与生物学评价
J Mol Struct. 2022 Sep 9:134128. doi: 10.1016/j.molstruc.2022.134128.
7
Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against and Biofilms.合成肽与抗真菌药物对[具体真菌名称]及生物膜的协同抗真菌活性 。(原文中“and”前后似乎缺失了具体内容)
Antibiotics (Basel). 2022 Apr 21;11(5):553. doi: 10.3390/antibiotics11050553.
8
Biofilm eradication and antifungal mechanism of action against Candida albicans of cationic dicephalic surfactants with a labile linker.具有不稳定连接基的阳离子双头表面活性剂对白色念珠菌的抗真菌作用及其生物膜清除作用。
Sci Rep. 2021 Apr 26;11(1):8896. doi: 10.1038/s41598-021-88244-1.
9
A Screen for Small Molecules to Target Biofilms.用于靶向生物膜的小分子筛选
J Fungi (Basel). 2020 Dec 27;7(1):9. doi: 10.3390/jof7010009.
10
Imaging of Candida albicans Hyphal Growth via Atomic Force Microscopy.通过原子力显微镜观察白念珠菌菌丝生长。
mSphere. 2020 Nov 4;5(6):e00946-20. doi: 10.1128/mSphere.00946-20.